Tag: International team finds trial drug that blocks early COVID-19 infection

International team finds trial drug that blocks early COVID-19 infection

April 13, 2020

A trial drug that appears to block the cellular door SARS-CoV-2 – the virus responsible for COVID-19 – uses to infect its hosts has been identified by a team of researchers from Canada, Spain and Sweden. The drug could very well stop early infection of the novel coronavirus and provide important information as to how […]

Continue Reading